Takeda Pharmaceutical Co Ltd

The U.S. Food and Drug Administration said on Tuesday it had approved Takeda Pharmaceutical Co Ltd's drug for a common type of viral infection occurring in patients after organ transplant.

Takeda Pharmaceutical Co, the Japanese partner for Novavax Inc's COVID-19 vaccine, is preparing to seek regulatory approval for a roll out in Japan early next year, its top executive said on Friday.

Takeda Pharmaceutical Co, the Japanese partner for Novavax Inc's COVID-19 vaccine, is preparing to seek regulatory approval for a roll out in Japan early next year, its top executive said on Friday.

Japan's Takeda Pharmaceutical Co said on Thursday half-year profit jumped and the drugmaker would buy back shares it viewed as undervalued. Operating profit rose 61% to 346 billion yen ($3.05 billion) in the six months through Sept. 30 from a year ago, driven by strong sales...

Japan's Takeda Pharmaceutical Co said on Thursday that its half-year profit rose 61% as the drugmaker tries to wring synergies out of its acquisition of Shire Plc.

Japan's Takeda Pharmaceutical Co Ltd said on Friday that "human error" caused metal contaminants to get into Moderna Inc COVID-19 vaccine doses, leading to a recall.

Japanese pharma company Takeda Pharmaceutical Co said on Wednesday the U.S. Food and Drug Administration approved its drug, Exkivity, to treat a type of lung cancer.

Takeda Pharmaceutical Co, which distributes Moderna Inc's COVID-19 shots in Japan, expects vaccines to become a bigger part of its portfolio as shots for dengue fever and COVID-19 near regulatory approval, its chief executive said.

Takeda Pharmaceutical Co said on Tuesday the Japanese government agreed to purchase 150 million doses of the COVID-19 vaccine it will produce using Novavax Inc's formula.

Moderna Inc and Takeda Pharmaceutical Co Ltd on Wednesday said they are working with Japanese authorities to recall three batches of COVID-19 vaccine after an investigation found stainless steel contaminants in some vials.

Moderna Inc said on Wednesday its Japanese distribution partner, Takeda Pharmaceutical Co Ltd, planned to initiate the recall of three lots of its COVID-19 vaccine that were suspended due to contamination.

Takeda Pharmaceutical Co Ltd lost its bid at the 2nd U.S. Circuit Court of Appeals on Wednesday to escape claims that it misdescribed its patents to the U.S. Food and Drug Administration to improperly delay generic versions of its blockbuster diabetes drug Actos.

Takeda Pharmaceutical Co has agreed to pay $1.85 million to settle claims by consumers that its predecessor Shire PLC delayed the launch of a generic version of its ADHD drug Intuniv through an illegal settlement with generic drugmaker Actavis.

Takeda Pharmaceutical Co said on Monday it will record a provision of about 63 billion yen ($574.56 million) in its financial statements for the first quarter to reflect a decision by Ireland's tax appeals body relating to tax assessment received by company's unit on a break...

Takeda Pharmaceutical Co said on Tuesday it agreed to supply an additional 50 million doses of Moderna Inc's COVID-19 vaccine to Japan.

Takeda Pharmaceutical Co on Tuesday said it may double imports of Moderna Inc's COVID-19 vaccine to help Japan speed up COVID-19 inoculation efforts that have trailed most wealthy countries.

Japanese drugmaker Takeda Pharmaceutical Co, which is importing Moderna Inc 's COVID-19 vaccine into Japan, said interim results of clinical trials ahead of domestic regulatory approvals have been positive.

Novavax Inc said on Friday the distribution of its COVID-19 vaccine in Japan is expected to begin in late 2021 or early 2022 and continue for the near-term, predicting the need for protection against variants in the future.

Japanese regulators are set to approve Moderna Inc's COVID-19 vaccine as soon as May 21, the Yomiuri Shimbun newspaper reported Saturday, without citing the source of the information.